Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Common Equity (2016 - 2026)

Sensus Healthcare has reported Common Equity over the past 11 years, most recently at $48.1 million for Q4 2025.

  • For Q4 2025, Common Equity fell 13.84% year-over-year to $48.1 million; the TTM value through Dec 2025 reached $48.1 million, down 13.84%, while the annual FY2025 figure was $48.1 million, 13.84% down from the prior year.
  • Common Equity for Q4 2025 was $48.1 million at Sensus Healthcare, down from $51.2 million in the prior quarter.
  • Over five years, Common Equity peaked at $55.8 million in Q4 2024 and troughed at $20.2 million in Q2 2021.
  • A 5-year average of $43.7 million and a median of $47.6 million in 2022 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: fell 16.82% in 2021 and later soared 128.68% in 2022.
  • Year by year, Common Equity stood at $26.0 million in 2021, then skyrocketed by 84.77% to $48.1 million in 2022, then grew by 1.61% to $48.8 million in 2023, then grew by 14.3% to $55.8 million in 2024, then decreased by 13.84% to $48.1 million in 2025.
  • Business Quant data shows Common Equity for SRTS at $48.1 million in Q4 2025, $51.2 million in Q3 2025, and $52.1 million in Q2 2025.